Woman in China first to die from bird flu strain: WHO

Woman in China first to die from bird flu strain: WHO

7:37am EST

BEIJING (Reuters) – A woman in China has died of the H10N8 strain of bird flu, the first ever reported human case of the virus, the World Health Organisation (WHO) said on Wednesday.The 73-year-old woman died from the virus on December 6, six days after contracting the disease, the WHO said in a statement.

The virus has been detected in birds since 1965 in at least seven countries including China, the WHO said.

The specific source of the woman’s infection was not known, the WHO said, although both wild birds and poultry were known to carry the virus and the patient had visited a live bird market four days before becoming ill.

The woman who died in Nanchang, the capital of landlocked southeastern province of Jiangxi, had an underlying medical condition, according to the WHO. Family members and other people she contacted had no symptoms and no other similar cases were detected in the area, it said.

There is currently no evidence of human-to-human transmission of the new H10N8 virus, say the authorities.

China is at the beginning of its traditional flu season, and has long had a problem with bird flu.

The H7N9 strain of bird flu emerged this year in China and has infected at least 139 people in China, Taiwan and Hong Kong, killing 45 of them.

Experts say there is no evidence of any easy or sustained human-to-human transmission of H7N9.

But a scientific analysis of probable transmission of the H7N9 virus from person to person, published in August, gave the strongest indication yet that it can at times jump between people and so could potentially cause a human pandemic.

Chinese authorities were investigating the case of H10N8 and had stepped up surveillance measures to detect and control infections, said the WHO.

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment